Viewing Study NCT05375903

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT05375903
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-14
First Post: 2022-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Sponsor: UroGen Pharma Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-muscle Invasive Bladder Cancer View
None NMIBC View
None Carcinoma in Situ of Bladder View
None Bladder Cancer View
None Urothelial Carcinoma Bladder View
None Urothelial Carcinoma Recurrent View
Keywords: